视频脑电图监测后手术在泰国成人药物难治性局灶性癫痫中的成本-效用分析
本研究评估泰国成人药物难治性局灶性癫痫患者接受视频脑电图(VEEG)监测后手术与继续药物治疗相比的成本-效用。基于决策树和马尔可夫模型估计终身成本和质量调整生命年(QALY),结果显示VEEG策略增量成本效果比为43,251泰铢(1236美元)/QALY,在泰国160,000泰铢/QALY阈值下有84%概率具有成本效果。
要点
- 术后第1年和第2年无发作率分别为79.4%和77.8%。
- VEEG策略较无VEEG策略增加1.50 QALY,增量成本效果比为43,251泰铢/QALY。
- 在泰国160,000泰铢/QALY阈值下,VEEG策略具有成本效果的概率为84%。
核心结论
- 对于药物难治性癫痫患者,VEEG监测后癫痫手术在泰国具有成本效果,因此应推荐纳入医疗保险覆盖范围。
研究设计与样本
- 采用决策树和马尔可夫模型,在终身时间 horizon 内估计总成本(泰铢,THB)和效果(质量调整生命年,QALY)。
- 短期手术结局、直接医疗成本和效用数据来自泰国一家专科医院的患者。
- 长期结局和手术相对于药物治疗的相对效果来自已发表文献的系统综述。
主要发现
- 术后第1年和第2年无发作率分别为79.4%和77.8%。
- VEEG和手术加1年随访护理的成本为216,782泰铢,其中VEEG和其他必要检查是主要成本驱动因素(42.8%)。
- 基于社会视角,40年时间范围内VEEG策略的总成本为1,168,679泰铢,比无VEEG策略高64,939泰铢。
- VEEG策略较无VEEG策略增加1.50 QALY,增量成本效果比为43,251泰铢(1236美元)/QALY。
- 关键参数变化对增量成本效果比影响极小;考虑不确定性,基于泰国160,000泰铢/QALY的成本效果阈值,VEEG策略具有成本效果的概率为84%。
临床怎么用
- 作者结论认为,对于药物难治性癫痫患者,VEEG监测后癫痫手术在泰国具有成本效果,因此应推荐纳入医疗保险覆盖范围。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study assessed whether video-electroencephalography (VEEG) monitoring followed by surgery was cost-effective in adult patients with drug-resistant focal epilepsy under Thai health care context, as compared with continued medical treatment without VEEG. METHODS: The total cost (in Thai Baht, THB) and effectiveness (in quality-adjusted life years, QALYs) were estimated over a lifetime horizon, using a decision tree and a Markov model. Data on short-term surgical outcomes, direct health care costs, and utilities were collected from Thai patients in a specialized hospital. Long-term outcomes and relative effectiveness of the surgery over medical treatment were derived, using systematic reviews of published literature. RESULTS: Seizure-free rates at years 1 and 2 after surgery were 79.4% and 77.8%, respectively. Costs of VEEG and surgery plus 1-year follow-up care were 216,782 THB, of which the VEEG and other necessary investigations were the main cost drivers (42.8%). On the basis of societal perspective, the total cost over a 40-year horizon accrued to 1,168,679 THB for the VEEG option, 64,939 THB higher than that for no VEEG. The VEEG option contributed to an additional 1.50 QALYs over no VEEG, resulting in an incremental cost-effectiveness ratio of 43,251 THB (USD 1236) per 1 QALY gained. Changes in key parameters had a minimal impact on the incremental cost-effectiveness ratio. Accounting for uncertainty, there was an 84% probability that the VEEG option was cost-effective on the basis of Thailand's cost-effective threshold of 160,000 THB/QALY. CONCLUSIONS: For patients with drug-resistant epilepsy, VEEG monitoring followed by epilepsy surgery was cost-effective in Thailand. Therefore it should be recommended for health insurance coverage.
引用
- Kitwitee P, Unnwongse K, Srikijvilaikul T, et al. Cost-Utility of Video-Electroencephalography Monitoring Followed by Surgery in Adults with Drug-Resistant Focal Epilepsy in Thailand. World Neurosurg. 2016. PMID: 27913266. doi:10.1016/j.wneu.2016.11.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。